Overview
CNO Financial Q2 net income falls to $91.8 mln from $116.3 mln
Net operating income declines 24% to $87.5 mln in Q2
Total new annualized premiums rise 17%
Outlook
CNO on track to meet 2025-2027 ROE targets
Company highlights strong capital position for future growth
CNO sees favorable demographic trends aiding profitability
Company remains focused on middle-income market needs
Result Drivers
SALES MOMENTUM - CNO reports 12th consecutive qtr of sustained sales momentum, with total new annualized premiums up 17%
UNDERWRITING MARGINS - Growing underwriting margins contributed to Q2 results, per CEO Gary C. Bhojwani
Key Details
Metric
Beat/Miss
Actual
Consensus Estimate
Q2 EPS
$0.91
Q2 Net Income
$91.80 mln
Q2 ROE
11.9%
Analyst Coverage
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 1 "strong buy" or "buy", 5 "hold" and 1 "sell" or "strong sell"
The average consensus recommendation for the life & health insurance peer group is "buy."
Wall Street's median 12-month price target for CNO Financial Group Inc is $42.00, about 10% above its July 25 closing price of $37.82
The stock recently traded at 9 times the next 12-month earnings vs. a P/E of 11 three months ago
Press Release: ID:nPn9YVnx1a
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)